arrow
Back
Y

Yuta Adachi

aichi cancer center research institute

13H-index
37Paper Count
1.0KCitation Count
Published Papers 15
Publication Date
Inhibiting KRAS with CD47 and immune checkpoint overcomes intrinsic resistance to combined KRAS and immune checkpoint inhibitor therapy
err2025-08-29
err0
errOAAI
errKentaro Hirade; Noritaka Tanaka; Taisuke Kajino; Yuta Adachi; Ryo Kimura; Hitomi Kasuya; Satoru Kisoda; Tze King Tan; Sho Hayakawa; Takahiko Sato; Shogo Yanase; Yoko Kitaura; Takamasa Yamamoto; Yuki Nishioka; Osamu Muto; Daisuke Muraoka; Teruaki Fujishita; Natsumi Kasuga; Kageaki Watanabe; Yoshihiko Sakata; Masahiro Aoki; Hirokazu Matsushita; Takaomi Sanda; Shinsuke Iida; Kohsuke Tsuchiya; Rui Yamaguchi; Hiromichi Ebi
errShare
errSave
Tetrapodal Hole-Collecting Monolayer Materials Based on Saddle-Like Cyclooctatetraene Core for Inverted Perovskite Solar Cells
err2024-09-23
err2
PREAI
errTruong, Minh Anh; Ueberricke, Lucas; Funasaki, Tsukasa; Adachi, Yuta; Hira, Shota; Hu, Shuaifeng; Yamada, Takumi; Sekiguchi, Naomu; Nakamura, Tomoya; Murdey, Richard; Iikubo, Satoshi; Kanemitsu, Yoshihiko; Wakamiya, Atsushi
errShare
errSave
SHP2 inhibitors maintain TGFβ signalling through SMURF2 inhibition
err2023-12-15
err0
errOAAI
errLai, Xianning; Lui, Sarah Kit Leng; Lam, Hiu Yan; Adachi, Yuta; Sim, Wen Jing; Vasilevski, Natali; Armstrong, Nicola J.; Bridgeman, Stephanie Claire; Main, Nathan Michael; Tan, Tuan Zea; Tirnitz-Parker, Janina E. E.; Thiery, Jean Paul; Ebi, Hiromichi; Kumar, Alan Prem; Eichhorn, Pieter Johan Adam
errShare
errSave
Scribble mis-localization induces adaptive resistance to KRAS G12C inhibitors through feedback activation of MAPK signaling mediated by YAP-induced MRAS
err2023-06-05
err29
PREAI
errAdachi, Yuta; Kimura, Ryo; Hirade, Kentaro; Yanase, Shogo; Nishioka, Yuki; Kasuga, Natsumi; Yamaguchi, Rui; Ebi, Hiromichi
errShare
errSave
ARAF protein kinase activates RAS by antagonizing its binding to RASGAP NF1
err2022-07-01
err15
errOAAI
errSu, Wenjing; Mukherjee, Radha; Yaeger, Rona; Son, Jieun; Xu, Jianing; Na, Na; Timaul, Neilawattie Merna; Hechtman, Jaclyn; Paroder, Viktoriya; Lin, Mika; Mattar, Marissa; Qiu, Juan; Chang, Qing; Zhao, Huiyong; Zhang, Jonathan; Little, Megan; Adachi, Yuta; Han, Sae-Won; Taylor, Barry S.; Ebi, Hiromichi; Abdel-Wahab, Omar; de Stanchina, Elisa; Rudin, Charles M.; Janne, Pasi A.; McCormick, Frank; Yao, Zhan; Rosen, Neal
errShare
errSave
High-risk neuroblastoma with NF1 loss of function is targetable using SHP2 inhibition
err2022-07-01
err10
errOAAI
errCai, Jinyang; Jacob, Sheeba; Kurupi, Richard; Dalton, Krista M.; Coon, Colin; Greninger, Patricia; Egan, Regina K.; Stein, Giovanna T.; Murchie, Ellen; McClanaghan, Joseph; Adachi, Yuta; Hirade, Kentaro; Dozmorov, Mikhail; Glod, John; Boikos, Sosipatros A.; Ebi, Hiromichi; Hao, Huaixiang; Caponigro, Giordano; Benes, Cyril H.; Faber, Anthony C.
errShare
errSave
EMT is a cause of both intrinsic and acquired resistance to KRAS G12C inhibitor in KRAS G12C mutant NSCLC
err2021-07-01
err0
PREAI
errAdachi, Yuta; Ito, Kentaro; Kimura, Ryo; Yamaguchi, Rui; Ebi, Hiromichi
errShare
errSave
Epithelial-to-Mesenchymal Transition is a Cause of Both Intrinsic and Acquired Resistance to KRAS G12C Inhibitor in KRAS G12C-Mutant Non-Small Cell Lung Cancer
err2020-11-13
err144
errOAAI
errAdachi, Yuta; Ito, Kentaro; Hayashi, Yuko; Kimura, Ryo; Tan, Tuan Zea; Yamaguchi, Rui; Ebi, Hiromichi
errShare
errSave
Reduced doses of dabrafenib and trametinib combination therapy for BRAF V600E-mutant non-small cell lung cancer prevent rhabdomyolysis and maintain tumor shrinkage: a case report
err2020-02-24
err4
errOAAI
errAdachi, Yuta; Yanagimura, Naohiro; Suzuki, Chiaki; Ootani, Sakiko; Tanimoto, Azusa; Nishiyama, Akihiro; Yamashita, Kaname; Ohtsubo, Koushiro; Takeuchi, Shinji; Yano, Seiji
errShare
errSave
AXL confers intrinsic resistance to osimertinib and the emergence of tolerant cells
err2019-07-01
err0
PREAI
errTaniguchi, Hirokazu; Yamada, Tadaaki; Wang, Rong; Tanimura, Keiko; Nishiyama, Akihiro; Tanimoto, Azusa; Adachi, Yuta; Takeuchi, Shinji; Yamaguchi, Hiroyuki; Fukuda, Minoru; Takayama, Koichi; Mukae, Hiroshi; Yano, Seiji
errShare
errSave
AXL confers intrinsic resistance to osimertinib and advances the emergence of tolerant cells
err2019-01-16
err240
errOAAI
errTaniguchi, Hirokazu; Yamada, Tadaaki; Wang, Rong; Tanimura, Keiko; Adachi, Yuta; Nishiyama, Akihiro; Tanimoto, Azusa; Takeuchi, Shinji; Araujo, Luiz H.; Boroni, Mariana; Yoshimura, Akihiro; Shiotsu, Shinsuke; Matsumoto, Isao; Watanabe, Satoshi; Kikuchi, Toshiaki; Miura, Satoru; Tanaka, Hiroshi; Kitazaki, Takeshi; Yamaguchi, Hiroyuki; Mukae, Hiroshi; Uchino, Junji; Uehara, Hisanori; Takayama, Koichi; Yano, Seiji
errShare
errSave
Distinct dependencies on receptor tyrosine kinases in the regulation of MAPK signaling between BRAF V600E and non-V600E mutant lung cancers
err2018-01-19
err27
PREAI
errKotani, Hiroshi; Adachi, Yuta; Kitai, Hidenori; Tomida, Shuta; Bando, Hideaki; Faber, Anthony C.; Yoshino, Takayuki; Voon, Dominic C.; Yano, Seiji; Ebi, Hiromichi
errShare
errSave
Resistance mediated by alternative receptor tyrosine kinases in FGFR1-amplified lung cancer
err2017-08-31
err19
errOAAI
errAdachi, Yuta; Watanabe, Kazuyoshi; Kita, Kenji; Kitai, Hidenori; Kotani, Hiroshi; Sato, Yuki; Inase, Naohiko; Yano, Seiji; Ebi, Hiromichi
errShare
errSave
Dominant role of receptor tyrosine kinase in the activation of MAPK signaling in BRAF non-V600 mutant cancers
err2017-07-01
err0
PREAI
errEbi, Hiromichi; Kotani, Hiroshi; Kitai, Hidenori; Adachi, Yuta; Yano, Seiji
errShare
errSave
Epithelial-to-Mesenchymal Transition Defines Feedback Activation of Receptor Tyrosine Kinase Signaling Induced by MEK Inhibition in KRAS-Mutant Lung Cancer
err2016-06-30
err136
errOAAI
errKitai, Hidenori; Ebi, Hiromichi; Tomida, Shuta; Floros, Konstantinos V.; Kotani, Hiroshi; Adachi, Yuta; Oizumi, Satoshi; Nishimura, Masaharu; Faber, Anthony C.; Yano, Seiji
errShare
errSave